RichardMBergenstalMD

Endocrinology • Minneapolis, MN

Diabetes, Lipid Metabolism

Executive Director, International Diabetes Center

Join to view full profile

Dr. Bergenstal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bergenstal's full profile

Already have an account?

Office
3800 Park Nicollet Blvd
Minneapolis, MN 55416
Phone+1 952-993-1913

Education & Training

University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1982
University of ChicagoResidency, Internal Medicine, 1976 - 1979
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1976

Certifications & Licensure

MN State Medical License 1983 - 2025
IL State Medical License 1977 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes Start of enrollment: 2004 Sep 01
Completed
Phase 4
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes Start of enrollment: 2006 Jan 01
Completed
Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data Start of enrollment: 2006 Apr 01
Completed
Glucose Meter Study Start of enrollment: 2008 Nov 01
Completed
Not Applicable
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide Start of enrollment: 2006 Dec 01
Completed
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control Start of enrollment: 2008 Apr 01
Completed
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine Start of enrollment: 2010 Apr 01
Completed
Not Applicable
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes Start of enrollment: 2010 Jun 01
Completed
Not Applicable
Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia Start of enrollment: 2010 Aug 01
Completed
Phase 4
Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes Start of enrollment: 2010 Oct 01
Completed
Not Applicable
Blood Glucose Monitoring System Clinical Study Start of enrollment: 2010 Dec 01
Completed
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Completed
Phase 3
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP) Start of enrollment: 2014 Mar 01
Completed
Not Applicable
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
Fuzzy Logic Automated Insulin Regulation Start of enrollment: 2019 Jun 03
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1203 citations
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann
The New England Journal of Medicine. 2016-07-28
592 citations
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial
Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode, Robert F. Kushner, Andrew Lewin
JAMA. 2015-08-18
464 citations
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W. Beck, Richard M. Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li
Diabetes Care. 2019-03-01

Journal Articles

Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
James R Gavin, Yogish C Kudva, Richard M Bergenstal, Davida F Kruger, Journal of the Endocrine Society

Lectures

Continuous Glucose Monitoring Systems: Uses and Abuses
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
Cardiometabolic Health Congress (CMHC 2012)
Cardiometabolic Health Congress, Boston, Massachusetts - 10/10/2012
Glucose Variability (Dysglycemia) and Diabetes Complications--Does It Matter? (Con)
Richard M. Bergenstal, MD - 6/14/2014

Press Mentions

Latest Data Shows That Most People with Diabetes Don’t Meet Glucose Targets. What Can Be Done? (ADA 2021)June 30th, 2021
American Diabetes Association, June 12-16June 21st, 2020
Abbott, Medtronic Go Head-to-Head at ADA ConferenceJune 15th, 2020
Join now to see all

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Member